Frankó, A. ; Berti, L. ; Hennenlotter, J.* ; Rausch, S.* ; Scharpf, M.O.* ; Hrabě de Angelis, M. ; Stenzl, A.* ; Birkenfeld, A.L. ; Peter, A. ; Lutz, S.Z.* ; Häring, H.-U. ; Heni, M.
     
 
    
        
Transcript levels of aldo-keto reductase family 1 subfamily C (AKR1C) are increased in prostate tissue of patients with type 2 diabetes.
    
    
        
    
    
        
        J. Pers. Med. 10:E124 (2020)
    
    
    
		
		
			
				Aldo-keto reductase family 1 (AKR1) enzymes play a crucial role in diabetic complications. Since type 2 diabetes (T2D) is associated with cancer progression, we investigated the impact of diabetes onAKR1gene expression in the context of prostate cancer (PCa) development. In this study, we analyzed benign (BEN) prostate and PCa tissue of patients with and without T2D. Furthermore, to replicate hyperglycemia in vitro, we treated the prostate adenocarcinoma cell line PC3 with increasing glucose concentrations. Gene expression was quantified using real-time qPCR. In the prostate tissue of patients with T2D,AKR1C1andAKR1C2transcripts were higher compared to samples of patients without diabetes. In PC3 cells, high glucose treatment induced the gene expression levels ofAKR1C1,C2,andC3. Furthermore, both in human tissue and in PC3 cells, the transcript levels ofAKR1C1, C2,andC3showed positive associations with oncogenes, which are involved in proliferation processes and HIF1 alpha and NF kappa B pathways. These results indicate that in the prostate glands of patients with T2D, hyperglycemia could play a pivotal role by inducing the expression ofAKR1C1, C2,andC3. The higher transcript level ofAKR1Cwas furthermore associated with upregulated HIF1 alpha and NF kappa B pathways, which are major drivers of PCa carcinogenesis.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Prostate Cancer ; Diabetes ; Aldo-keto Reductase Family 1 ; Hif1a ; Nfkb; In-vitro; Cancer; Androgen; Overexpression; Inflammation; Expression; Metabolism; Mortality; Hypoxia; Risk
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2020
    
 
    
        Prepublished im Jahr 
        
    
 
    
        HGF-Berichtsjahr
        2020
    
 
    
    
        ISSN (print) / ISBN
        2075-4426
    
 
    
        e-ISSN
        2075-4426
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 10,  
	    Heft: 3,  
	    Seiten: ,  
	    Artikelnummer: E124 
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            MDPI
        
 
        
            Verlagsort
            Basel, Switzerland
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        90000 - German Center for Diabetes Research
30201 - Metabolic Health
    
 
    
        Forschungsfeld(er)
        Helmholtz Diabetes Center
Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-502400-001
G-500600-001
G-501900-065
    
 
    
        Förderungen
        German Federal Ministry of Education and Research (BMBF)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2020-09-23